Short B G
Department of Toxicology-U.S., SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406.
Environ Health Perspect. 1993 Dec;101 Suppl 5(Suppl 5):115-20. doi: 10.1289/ehp.93101s5115.
Enhanced cell proliferation occurs at several stages of renal tumorigenesis. Initiation by genotoxic nephrocarcinogens such as dimethylnitrosamine (DMN) is likely a result of DNA damage coupled with an initial burst of DNA synthesis associated with the cytotoxic effects of the compound. The level of initiation by DMN can be further enhanced by unilateral nephrectomy or hydronephrosis, which induces a brief burst of cell proliferation followed by tumorigenesis in the contralateral kidney. The role of sustained cell proliferation in renal tumor development is less well understood. The most compelling evidence comes from studies with nongenotoxic renal carcinogens such as unleaded gasoline and d-limonene, which induce alpha 2u-globulin (alpha G) nephropathy and renal epithelial tumors exclusively in male rats. Sustained increases in cell proliferation in these studies depend on the presence of a chemical-alpha G complex in phagolysosomes of P2 proximal tubule cells, which results in cytotoxicity and compensatory hyperplasia only in male F344 rats, but not female F344 rats or alpha G deficient male NBR rats. Furthermore, initiation-promotion experiments demonstrated a strong correlation between the dose-response of cell proliferation and the incidence of preneoplastic and neoplastic lesions. Clearly, similar correlative studies with a number of other renal carcinogens and non-carcinogens are warranted before general conclusions can be made. Cell proliferation is excessively elevated in tubules affected by chronic progressive nephropathy, but the significance of the lesion to renal carcinogenesis is unclear. Elucidating mechanisms of renal cell proliferation are necessary for our understanding of cause and effect relationships. An exciting recent finding is altered expression of transforming growth factor-alpha in hereditary rat renal cell carcinoma.(ABSTRACT TRUNCATED AT 250 WORDS)
增强的细胞增殖发生在肾肿瘤发生的几个阶段。由基因毒性肾致癌物如二甲基亚硝胺(DMN)引发肿瘤,可能是DNA损伤与该化合物细胞毒性作用相关的DNA合成初始爆发的结果。DMN引发肿瘤的水平可通过单侧肾切除或肾积水进一步增强,这会诱导对侧肾脏短暂的细胞增殖爆发,随后发生肿瘤形成。持续细胞增殖在肾肿瘤发展中的作用尚不太清楚。最有说服力的证据来自对非基因毒性肾致癌物的研究,如无铅汽油和d-柠檬烯,它们仅在雄性大鼠中诱发α2u球蛋白(αG)肾病和肾上皮肿瘤。在这些研究中,细胞增殖的持续增加取决于P2近端小管细胞吞噬溶酶体中化学物质-αG复合物的存在,这仅在雄性F344大鼠中导致细胞毒性和代偿性增生,而在雌性F344大鼠或αG缺陷雄性NBR大鼠中则不会。此外,启动-促进实验表明细胞增殖的剂量反应与癌前和肿瘤性病变的发生率之间存在很强的相关性。显然,在得出一般性结论之前,有必要对许多其他肾致癌物和非致癌物进行类似的相关性研究。在受慢性进行性肾病影响的肾小管中,细胞增殖过度升高,但该病变对肾致癌作用的意义尚不清楚。阐明肾细胞增殖机制对于我们理解因果关系是必要的。最近一个令人兴奋的发现是遗传性大鼠肾细胞癌中转化生长因子-α的表达改变。(摘要截短至250字)